Communiqués de presse 24-7 Press Release — Industry: Biotechnology — Flux RSS et veille en direct
PPN World indexe les communiqués de presse de 24-7 Press Release — Industry: Biotechnology et en archive chaque publication. Ce fil est silencieux depuis le 1 juillet 2026 — ses 29 communiqués indexés restent consultables, et une alerte vous préviendra dès qu'il publiera de nouveau.
URL du flux RSS de 24-7 Press Release — Industry: Biotechnology
https://rss.24-7pressrelease.com/rss/industry_biotechnology.xmlÀ propos de ce fil
24-7 Press Release — Industry: Biotechnology fait partie des 900+ fils de presse que PPN World surveille en continu — un fil en anglais axé sur le secteur Biotech, classé sous « États-Unis » dans notre index par pays. Chaque communiqué est dédupliqué, géolocalisé et enrichi d'un résumé IA, et vous pouvez y attacher des alertes sur recherches enregistrées. Le communiqué le plus récent de notre index a été publié le 1 juillet 2026; le fil est silencieux depuis.
Comment suivre les communiqués de 24-7 Press Release — Industry: Biotechnology
- Copiez l'URL du flux RSS de 24-7 Press Release — Industry: Biotechnology affichée ci-dessus.
- Collez-la dans n'importe quel lecteur RSS (Feedly, Inoreader, NetNewsWire…) pour recevoir le flux brut.
- Ou suivez 24-7 Press Release — Industry: Biotechnology dans PPN World pour ajouter déduplication, alertes sur recherches enregistrées et résumés IA sur les 900+ fils.
Communiqués de 24-7 Press Release — Industry: Biotechnology — archives
- Next-Generation Precision Obesity Models: Closing the Translational Gap in Anti-Obesity Drug Developmentil y a 11 j
Moving Beyond the Scale—How Precision-Engineered Models Are Redefining Preclinical Obesity Research
- Creative Biolabs: Custom Oligosaccharide Synthesis and Glycan Characterization for Drug Discoveryil y a 12 j
Creative Biolabs has expanded its custom oligosaccharide synthesis and glycan characterization services to help researchers overcome challenges in glycan synthesis, purification, structural analysis,…
- Ace Therapeutics Announces Comprehensive Preclinical Analgesic Drug Development Services with Full-Spectrum Pain Research Platformil y a 12 j
Ace Therapeutics announces its robust end-to-end solutions dedicated to advancing pain therapeutic development, featuring diverse validated in vivo pain models for drug testing.
- Alfa Chemistry Advances Colloidal Stability Engineering for High-Performance Nanodispersion Systemsil y a 12 j
Integrated Colloidal Materials and Application Solutions Help Researchers Optimize Particle Stability Across Semiconductor, Catalysis, and Functional Materials Workflows
- Creative Diagnostics Launches Hantavirus Research Reagents and Products to Accelerate Global Diagnostic and Vaccine Researchil y a 16 j
Creative Diagnostics announces Hantavirus Research Reagents and Products to support hantavirus research and diagnostic assay development.
- Ace Therapeutics Launches Full-Scale Preclinical Hematology CRO Services with Expanded In Vivo Hematologic Disease Modelsil y a 16 j
Ace Therapeutics announces its comprehensive suite of integrated preclinical hematology CRO services designed to accelerate the discovery and regulatory advancement of novel therapeutics for a broad s…
- Creative Biolabs Supports Neurodegeneration Research with Advanced iPSC Modelsil y a 18 j
Creative Biolabs helps researchers address key challenges in neurodegenerative disease research through iPSC-derived neuronal differentiation services and disease-specific cell models.
- Creative Biolabs Launches End-to-End ASO Development Servicesil y a 23 j
To address stability and targeted delivery challenges in RNA therapeutics, Creative Biolabs introduces its comprehensive, one-stop antisense oligonucleotide (ASO) development platform, streamlining wo…
- Creative Biolabs Accelerates Metabolic Disease Drug Discovery with Deep Learning for Multi-Receptor Agonist Designil y a 24 j
Creative Biolabs has upgraded its AI-driven functional protein solutions, empowering industrial biotechnology clients to rapidly screen millions of peptide sequences.
- Daniel Yansura Presented with the Albert Nelson Marquis Lifetime Achievement Award by Marquis Who's Whoil y a 33 j
Daniel Yansura has been endorsed by Marquis Who's Who as a leader in molecular biology and research
- NEW HORIZON MEDICAL SOLUTIONS PROMOTES RAYMOND JESSEN, MPH, MHSA, CTBS TO SENIOR VICE PRESIDENT OF COMPLIANCE, REGULATORY AFFAIRS & QUALITYil y a 40 j
Seasoned Regulatory and Compliance Leader Elevated to Strengthen Quality Infrastructure Across NHMS's Medical Device and Regenerative Medicine Portfolio
- Creative Biolabs Advances Anti‑Glycan Antibody Discovery for Glycan‑Shielded Virusesil y a 44 j
Creative Biolabs addresses major challenges in glycan-shielded virus research with advanced anti-glycan antibody development services for Ebola, Marburg, flavivirus, and other emerging pathogens.
Les plus récents communiqués de ce fil défilent en direct pour les membres PPN World.